• Therapeutic cancer vaccine
  • Anti-Lung Cancer Antibody
Therapeutic cancer vaccine:
Recombinant human ErbB3 fragment (rhErbB3-f) immunization. rhErbB3-f is a recombinant human ErbB3 receptor fragment produced by expression in E. coli. After purification and formulation with adjuvant, it can be used for immunization to induce the production of specific anti-ErbB3 antibodies for the treatment of patients with breast cancer characterized by the overexpression of ErbB2. rhErbB3-f, therefore, is as a therapeutic cancer vaccine.
Anti-lung cancer antibody
A monoclonal antibody has been tested in humans for the diagnosis of lung cancer (SCLC). We are looking for a partner for clinical development as a therapy or a diagnostic tool.